The need for additional safeguards in the informed consent process in schizophrenia research

AUTOR(ES)

Anderson, Kelly K

FONTE

BMJ Group

RESUMO

The process of obtaining informed consent to participate in a clinical study presents many challenges for research conducted in a population of patients with schizophrenia. Morally valid, informed consent must include information sharing, decisional capacity, and capacity for voluntarism. This paper examines the unique features of schizophrenia that may threaten each of these elements of informed consent, and it proposes additional safeguards in the process of gaining informed consent from individuals with schizophrenia in order to maximise the decision‐making potential of this patient population.

Documentos Relacionados

• The Use of Multimedia in the Informed Consent Process
• Optimizing the HIV/AIDS informed consent process in India
• Informed consent and research design in critical care medicine
• Some observations on informed consent in non-therapeutic research.
• Novel consent process for research in dying patients unable to give consent